Table 1.
Mean ± S.D. (median) and reference interval at 95th percentiles recorded during the outbreak (CI: controls; TI: cats treated with recombinant feline interferon-ω) and 1 month later (CII: controls; TII: cats treated with recombinant feline interferon-ω)
| CI | TI | CII | TII | |
|---|---|---|---|---|
| Alb | 2.72 ± 0.72 (2.75) | 2.25 ± 0.49 (2.45) | 3.48 ± 1.92 (3.48) | 3.31 ± 0.86 (2.96) |
| (g/dl) | 1.57–3.58 | 1.41–2.78 | 2.19–4.76 | 2.50–4.43 |
| α1-glob | 0.48 ± 0.16 (0.45) | 0.32 ± 0.12* (0.34) | 0.18 ± 0.09 (0.18) | 0.24 ± 0.15 (0.18) |
| (g/dl) | 0.31–0.77 | 0.11–0.49 | 0.11–0.24 | 0.15–0.48 |
| α2-glob | 0.72 ± 0.38 (0.67) | 0.57 ± 0.27 (0.57) | 0.40 ± 0.21 (0.40) | 0.60 ± 0.12 (0.55) |
| (g/dl) | 0.36–1.44 | 0.24–1.07 | 0.26–0.54 | 0.49–0.75 |
| β-glob | 0.98 ± 0.33 (0.86) | 0.87 ± 0.26 (0.85) | 0.70 ± 0.39 (0.70) | 0.72 ± 0.10 (0.76) |
| (g/dl) | 0.64–1.58 | 0.49–1.38 | 0.43–0.96 | 0.57–0.81 |
| γ-glob | 1.00 ± 0.42 (0.86) | 1.06 ± 0.63 (1.05) | 0.81 ± 0.29 (0.81) | 2.44 ± 0.71† (2.66) |
| (g/dl) | 0.58–1.67 | 0.13–2.15 | 0.61–1.00 | 1.65–3.23 |
| AGP | 0.17 ± 0.08 (0.17) | 0.10 ± 0.07* (0.09) | 0.06 ± 0.04 (0.06) | 0.05 ± 0.04 (0.03) |
| (mg/ml) | 0.04–0.28 | 0.03–0.25 | 0.03–0.09 | 0.02–0.11 |
| IgG | 0.55 ± 0.43 (0.35) | 0.67 ± 0.53 (0.59) | 0.66 ± 0.31 (0.66) | 1.64 ± 0.35† (1.85) |
| (g/dl) | 0.19–1.32 | 0.14–1.78 | 0.45–0.87 | 1.15–1.91 |
| IgM | 0.24 ± 0.13 (0.20) | 0.56 ± 0.46 (0.55) | 0.22 ± 0.03 (0.22) | 0.39 ± 0.21 (0.38) |
| (g/dl) | 0.07–0.38 | 0.07–1.37 | 0.20–0.24 | 0.20–0.69 |
| IgG–FPV | 1:144 ± 1:169 (1:50) | 1:194 ± 1:457 (1:25) | 1:300 ± 1:141 (1:300) | 1:1160 ± 1:1268† (1:400) |
| 1:4–1:400 | 0–1:1270 | 1:205–1:395 | 1:220–1:3040 | |
| IgM–FPV | 1:16 ± 1:19 (1:12) | 1:50 ± 1:58 (1:25) | 1:37 ± 1:18 (1:37) | 1:75 ± 1:79 (1:50) |
| 0–1:46 | 0–1:172 | 1:25–1:50 | 1:2–1:190 | |
*
P < 0.05 vs. CI.
†
P < 0.05 vs. CII and vs. TI.